333

S.BIOMEDICS

No trades
See on Supercharts
Market capitalization
‪376.74 B‬KRW
‪−7.52 B‬KRW
‪13.11 B‬KRW
‪6.00 M‬
Beta (1Y)
−0.85

About S.BIOMEDICS

Headquarters
Seoul
Employees (FY)
54
Founded
2003
ISIN
KR7304360001
FIGI
BBG01F7NP2D1
S.Biomedics Co. Ltd. operates as a biotechnology company. It engages in the research and development of cell therapies for regenerative biomedicine. The company was founded in August 2003 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 304360 is 33450 KRW — it has decreased by 8.86% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange S.BIOMEDICS stocks are traded under the ticker 304360.
304360 stock is 11.89% volatile and has beta coefficient of −0.85. Check out the list of the most volatile stocks — is S.BIOMEDICS there?
Yes, you can track S.BIOMEDICS financials in yearly and quarterly reports right on TradingView.
304360 stock has fallen by 11.74% compared to the previous week, the month change is a 196.81% rise, over the last year S.BIOMEDICS has showed a 44.49% increase.
304360 net income for the last quarter is ‪−1.89 B‬ KRW, while the quarter before that showed ‪−1.99 B‬ KRW of net income which accounts for 5.07% change. Track more S.BIOMEDICS financial stats to get the full picture.
No, 304360 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 304360 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade S.BIOMEDICS stock right from TradingView charts — choose your broker and connect to your account.
304360 reached its all-time high on Apr 22, 2024 with the price of 49500 KRW, and its all-time low was 6950 KRW and was reached on Nov 13, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 30, 2024, the company has 54.00 employees. See our rating of the largest employees — is S.BIOMEDICS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So S.BIOMEDICS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating S.BIOMEDICS stock shows the strong buy signal. See more of S.BIOMEDICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. S.BIOMEDICS EBITDA is ‪−4.48 B‬ KRW, and current EBITDA margin is −46.00%. See more stats in S.BIOMEDICS financial statements.